CClinicalTrials.gg
CompletedNCT03289000Updated Oct 25, 2023

A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System

An observational study in Osteo Arthritis Knee, sponsored by Restor3D. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Restor3D · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
93
Ages
18 Years and older
Sex
All
01

Study summary

This study is a retrospective, multi-center study, with one single remote follow up contact. This study will include a minimum of 80 patients and a maximum 100 patients who have been treated with the ConforMIS iTotal PS knee product.

Read the detailed description

Patients will be contacted either by phone or email for a single remote follow-up. Retrospective data will be collected from medical records including pre-operative, operative and any follow up visits which have occurred since implantation as available. . All data will be collected from existing medical records and from single follow up call/email.

  • Demographics and Medical History
  • Pre \& Post-Operative Data including Range of Motion
  • Surgical Data
  • Survivorship (phone/email or last known visit)
  • Patient Reported Outcomes (phone/email single time point visit)

    • Patient Satisfaction
    • KOOS Jr.
02

Conditions studied

  • Osteo Arthritis Knee

Keywords

  • osteoarthritis
  • knee arthroplasty
  • knee replacement
  • patient specific
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals who are 18 years or older and have received a ConforMIS iTotal PS knee replacement to treat any condition indicated on the device's instructions for use.

Inclusion criteria

  1. Previously underwent surgical implantation of a ConforMIS iTotal PS knee replacement.
  2. Over 18 Years of age

Exclusion criteria

Exclusion Criteria:

  1. BMI > 40
04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
93 participants (actual)
Patient registry
No

Groups and cohorts

  • ConforMIS PS Group

    Patients who have undergone a total knee replacement with the ConforMIS iTotal PS Knee Replacement System

    Device: iTotal Posterior Stabilized (PS) Knee Replacement System

Interventions

  • DeviceiTotal Posterior Stabilized (PS) Knee Replacement System

    Patient-specific posterior stabilized total knee replacement and patient specific surgical jigs

05

What researchers measure

Primary outcomes

  1. Demographics and Medical History

    Demographics and medical history gathered from medical records

    Time frame: 1 year

  2. Pre and Post Operative Range of Motion

    Collected retrospectively through medical records, collecting range of motion from pre-operative visits and post-operative visits

    Time frame: 1 year

06

Study locations

2 sites
  • Tennessee Orthopaedic Alliance
    Nashville, Tennessee 37203, United States
  • Scott Orthopedic Center
    Huntington, West Virginia 25702, United States
07

Registry details

Key details

Study ID
NCT03289000
Lead sponsor
Restor3D
Responsible party
Sponsor
First posted
Sep 20, 2017
Start date
Apr 24, 2017
Primary completion
Aug 4, 2017
Completion
Dec 31, 2017
Last update
Oct 25, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion